Skip to content

Effect of the test product on dandruff control

A clinical study to evaluate the Anti-dandruff efficacy of ayurvedic products - NIL

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2023/09/057704
Enrollment
275
Registered
2023-09-15
Start date
Unknown
Completion date
Unknown
Last updated
2023-10-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

None listed

Sponsors

Hindustan Unilever Limited
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Volunteer presenting moderate to severe dandruff (at least shoulder length hair for females) as per dermatological assessment. 2. Volunteer in good health condition as per the medical screening criteria with no disease state or physical condition that the Investigator believes could interfere with the interpretation of the data. 3. Volunteer able to read, understand and sign an appropriate informed consent form indicating her willingness to participate. 4. Volunteers agreeing to comply with following study restrictions: - Volunteers Willing to refrain from application of any other product/treatment on their scalp and hair shafts during the study period. - Not to apply any cosmetic, hair care product, test product and/or water 48 hours before scheduled visits. - Willing not to colour or dye their hair just before the study visits and during the study period

Exclusion criteria

Exclusion criteria: 1. Volunteer pregnant or planning to become pregnant. 2. Volunteers who are breastfeeding or having stopped to breastfeed in the past three months. 3. Volunteers with any other signs of significant local irritation, erythema or skin disease on scalp as well as on the visible parts of the body skin site. 4. Volunteers with self-perceived sensitive skin. 5. Volunteers having chronic illness or had major surgery in the last year. 6. Volunteers undergoing any treatment of any skin condition on body. 7. Volunteers taking medication continuously/regularly every day such as corticosteroids or non-steroidal anti-inflammatories, topically for four weeks or orally for eight weeks prior to the study. 8. Volunteers taking medication for any condition which the Investigator believes may influence the interpretation of the data. 9. Volunteers on food supplements

Design outcomes

Primary

MeasureTime frame
Significant reduction in dandruff flakesTimepoint: Basline, Week 1, Week 2, Week 4. Week 5

Secondary

MeasureTime frame
Significant reduction in scalp itchTimepoint: Basline, Week 1, Week 2, Week 4. Week 5

Countries

India

Contacts

Public ContactDr Mohit Lalvani

MASCOT-SPINCONTROL India Pvt. Ltd.

raji@mascotspincontrol.in02243349191

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026